![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 41, 29529-29535, October 8, 1999
From the Institut für Pharmakologie und Toxikologie, Recent evidence suggests the expression of a
Na+/Ca2+ exchanger (NCX) in vascular
endothelial cells. To elucidate the functional role of endothelial NCX,
we studied Ca2+ signaling and
Ca2+-dependent activation of endothelial
nitric-oxide synthase (eNOS) at normal, physiological Na+
gradients and after loading of endothelial cells with Na+
ions using the ionophore monensin. Monensin-induced Na+
loading markedly reduced Ca2+ entry and, thus, steady-state
levels of intracellular free Ca2+
([Ca2+]i) in thapsigargin-stimulated endothelial
cells due to membrane depolarization. Despite this reduction of overall [Ca2+]i, Ca2+-dependent
activation of eNOS was facilitated as indicated by a pronounced
leftward shift of the Ca2+ concentration response curve in
monensin-treated cells. This facilitation of
Ca2+-dependent activation of eNOS was strictly
dependent on the presence of Na+ ions during treatment of
the cells with monensin. Na+-induced facilitation of eNOS
activation was not due to a direct effect of Na+ ions on
the Ca2+ sensitivity of the enzyme. Moreover, the effect of
Na+ was not related to Na+ entry-induced
membrane depolarization or suppression of Ca2+ entry, since
neither elevation of extracellular K+ nor the
Ca2+ entry blocker
1-( The endothelial isoform of nitric-oxide synthase
(eNOS)1 is constitutively
expressed in endothelial cells and cardiac myocytes and dynamically
regulated by Ca2+/calmodulin. The enzyme is unique among
the three known NOS isoforms in being targeted to specialized cell
surface signal-transducing domains termed plasmalemmal caveolae (1, 2).
This feature appears to allow for an efficient control of eNOS
activity, as numerous signaling molecules such as G-protein-coupled
receptors, the plasma membrane Ca2+ pump, an inositol
1,4,5-trisphosphate-sensitive Ca2+ channel, and protein
kinase C are enriched in caveolae (3, 4). The targeting of eNOS to
caveolae is promoted by direct interaction of the enzyme with the
caveolae structural protein, caveolin-1. The interaction of eNOS with
caveolin-1 renders the enzyme inactive, apparently due to a functional
competition between caveolin-1 and Ca2+/calmodulin (5-7).
In the presence of high concentrations of Ca2+, the
NOS-caveolin complex dissociates, and a catalytically active NOS-Ca2+/calmodulin complex is formed.
Although it is well established that depletion of intracellular
Ca2+ stores and capacitative Ca2+ entry across
the endothelial plasma membrane are key events in endothelial
Ca2+ signaling (8-10), little is known about the role of
individual Ca2+ transport systems in eNOS regulation.
Recent studies provide evidence that significant increases in
subplasmalemmal [Ca2+]i, which may well be
sufficient for enzyme activation, may occur even in the absence of
detectable changes in perinuclear [Ca2+]i,
suggesting that focal elevations in subplasmalemmal [Ca2+]i rather than increases in overall
[Ca2+]i trigger NO biosynthesis in endothelial
cells (11, 12). Thus, the subcellular Ca2+ distribution and
the subplasmalemmal Ca2+ concentration at the caveolae may
be of particular importance for modulation of eNOS activity. It has
recently been postulated that endothelial subplasmalemmal
[Ca2+]i may be controlled for a large part by
Na+/Ca2+ exchange (11). This Ca2+
transport system was first identified in cardiac muscle (13) and
transports Ca2+ in exchange for Na+ in either
direction, depending on the electrochemical gradients of
Na+ and Ca2+ (14, 15). In the forward mode
(Na+ entry/Ca2+ extrusion), the exchanger
represents the primary mechanism for Ca2+ efflux in the
myocardium and thus plays a prominent role in contractile function
(15-17). During depolarization, the exchanger operates in reversed
mode (Ca2+ entry/Na+ extrusion) and triggers
Ca2+-induced Ca2+ release during cardiac
excitation (18, 19).
In endothelial cells, the presence of a
Na+/Ca2+ exchanger (NCX) has recently been
demonstrated by immunoblotting and immunofluorescence microscopy (20),
and these results have been verified by the detection of cDNA
coding for NCX1 (21). However, the role of this protein in endothelial
Ca2+ homeostasis is still a matter of debate. Since
inhibition of NCX diminished the endothelium-dependent
relaxation of arteries (22, 23), it has been suggested that reversed
mode Na+/Ca2+ exchange may contribute to the
plateau phase of [Ca2+]i after agonist
stimulation of endothelial cells (24). However, no change in overall
[Ca2+]i was observed when extracellular
Na+ was replaced by
N-methyl-D-glucamine or Li+ in
resting or bradykinin-stimulated endothelial cells (25, 26).
Nonetheless, a significant increase in [Ca2+]i
was observed when extracellular Na+ was replaced by
Li+ in endothelial cells that were Na+-loaded
by a preceding incubation with the Na+ ionophore monensin
(26). Thus, changes in [Ca2+]i due to
Na+/Ca2+ exchange are clearly detectable when
the intracellular Na+ concentration is elevated, supporting
the hypothesis that Na+/Ca2+ exchange
contributes to Ca2+ homeostasis in endothelial cells.
The present study was designed to elucidate the functional relevance of
Na+/Ca2+ exchange for
Ca2+-dependent activation of eNOS in cultured
porcine aortic endothelial cells. We provide evidence for facilitation
of eNOS activation due to reversed mode
Na+/Ca2+ exchange.
Materials--
FURA-2/AM was obtained from Lambda Fluorescence
Technology (Graz, Austria).
L-[2,3,4,5-3H]Arginine hydrochloride (57 Ci/mmol) and the ECL Western blotting detection system were from
Amersham Pharmacia Biotech. SK&F 96365 (1-( Cell Culture--
Porcine aortic endothelial cells were isolated
as described (28) and cultured at 37 °C, 5% CO2 up to 3 passages in Dulbecco's modified Eagle's medium containing 10%
heat-inactivated fetal calf serum, 100 units/ml penicillin, 0.1 mg/ml
streptomycin, and 1.25 µg/ml amphotericin B.
Determination of Intracellular Ca2+ Levels in
Store-depleted Endothelial Cells--
[Ca2+]i
was determined using the Ca2+ indicator FURA-2 as described
previously (29, 30). Briefly, endothelial cells were harvested,
suspended in Dulbecco's modified Eagle's medium (~106
cells/ml), and incubated with 2 µM FURA-AM at 37 °C.
After 45 min, cells were washed and resuspended in nominal
Ca2+-free incubation buffer (50 mM HEPES
buffer, pH 7.4, containing 100 mM NaCl, 5 mM
KCl, 1 mM MgCl2 and 0.1 mM EGTA).
Where indicated, 100 mM NaCl was replaced by 100 mM choline chloride (nominal Na+-free buffer)
or 100 mM KCl + 20 mM NaCl (high K+
buffer). Fluorescence measurements were carried out at 37 °C at
excitation wavelengths of 340 and 380 nm and an emission wavelength of
510 nm. Experiments were started by the addition of 0.1 µM thapsigargin and, where indicated, 1 µM
monensin or 30 µM SK&F 96365. After 15 min, aliquots of
Ca2+ stock solutions were added to obtain the indicated
concentrations of extracellular Ca2+, which were determined
in parallel experiments with a Ca2+-sensitive electrode.
[Ca2+]i was calculated using the ratio of
fluorescence intensity at 340/380 nm.
Determination of eNOS Activity in Store-depleted Endothelial
Cells--
NOS activity in intact cells was determined by monitoring
the conversion of L-[3H]arginine into
L-[3H]citrulline as described previously (31,
32). Briefly, endothelial cells grown in 6-well plates were washed with
nominal Ca2+-free incubation buffer, nominal
Na+-free buffer, or high K+ buffer (see above)
and preincubated for 15 min at 37 °C in the presence of 100 nM thapsigargin and, where indicated, with 1 µM monensin or 30 µM SK&F 96365. Reactions
were started by addition of
L-[2,3,4,5-3H]arginine (~ 106
dpm) and CaCl2 (final concentration 0.01 to 10 mM) and terminated after 10 min by washing the cells with
ice-cold 50 mM HEPES buffer, pH 7.4, containing 100 mM NaCl, 5 mM KCl, 1 mM
MgCl2, and 5 mM EDTA. Subsequent to lysis of
the cells with 1 ml of 0.01 N HCl for 1 h, an aliquot
of 0.1 ml was removed for determination of incorporated radioactivity.
To the remaining sample, 0.1 ml of 200 mM sodium acetate
buffer, pH 13.0, containing 10 mM L-citrulline was added (final pH ~ 5.0), and
L-[3H]citrulline was separated from
L-[3H]arginine by cation exchange
chromatography. Values are expressed as % conversion of incorporated
L-[3H]arginine into
L-[3H]citrulline.
Determination of eNOS Activity in Resting and
Bradykinin-stimulated Endothelial Cells--
Endothelial cells grown
in 6-well plates were washed with 50 mM HEPES buffer, pH
7.4, containing 2.5 mM CaCl2, 5 mM
KCl, 1 mM MgCl2, and 100 mM NaCl or
choline chloride and preincubated for 15 min at 37 °C in the absence
or presence of 1 µM monensin. Reactions were started by
addition of L-[2,3,4,5-3H]arginine
(~106 dpm) and H2O or bradykinin (final
concentration 0.1 nM to 1 µM). After 3 min,
incubation was terminated, and conversion of incorporated L-[3H]arginine into
L-[3H]citrulline was determined as described above.
Isolation of Caveolin-rich Membrane Fractions--
Caveolae
membranes were isolated by a method adapted from Song et al.
(33). Briefly, endothelial cells were harvested, washed twice with
ice-cold phosphate-buffered saline (PBS), and resuspended in 2 ml of
0.5 M sodium carbonate, pH 11.0 (2 × 107
cells/ml). Cells were homogenized by sonication, and the homogenate was
adjusted to 45% sucrose by adding 2 ml of 90% sucrose prepared in MBS
(25 mM MES, pH 6.5, 0.15 M NaCl). 1.8 ml of the
45% sucrose homogenate was placed at the bottom of a 4-ml
ultracentrifuge tube overlaid by 1.8 ml of 35% and 0.4 ml of 5%
sucrose (each prepared in MBS containing 0.25 M sodium
carbonate) and centrifuged for 20 h at 134,000 × g. From the top of the gradient, 0.4-ml fractions were
collected and mixed with 0.1 ml of a solution of 50% trichloroacetic
acid. After centrifugation, the precipitated proteins were either
dissolved in 0.1 ml of 1 N NaOH for the determination of
total protein or in 0.1 ml of Laemmli buffer for immunoblotting experiments.
Immunoblotting of Gradient Fractions--
Proteins dissolved in
Laemmli buffer (30-µl aliquots) were separated by
SDS-polyacrylamide gel electrophoresis (8% acrylamide for eNOS und
NCX, 12% acrylamide for caveolin-1) and transferred to nitrocellulose
as described previously (34). For immunoblotting, nitrocellulose sheets
were preincubated for 1 h at room temperature with TBST buffer (25 mM Tris, pH 7.4, 137 mM NaCl, 2.7 mM KCl, and 0.1% Tween 20) containing 3% ovalbumin and
incubated with TBST buffer containing 0.5% ovalbumin and an antibody
against caveolin-1 (dilution 1/1,000, incubation at room temperature
for 1 h), eNOS (dilution 1/5,000, incubation at room temperature
for 1 h), or NCX (dilution 1/15,000, incubation overnight at
4 °C). After washing with TBST buffer, nitrocellulose sheets were
incubated for 1-2 h at room temperature with the respective second
antibody (dilution 1/5,000-1/15,000). For detection of the proteins,
the ECL system from Amersham Pharmacia Biotech was used.
Immunofluorescence Microscopy--
Endothelial cells, cultured
on glass coverslips, were washed twice with PBS and fixed in PBS
containing 3.7% formaldehyde and 1.5% methanol for 10 min at room
temperature (35). After two washes with 0.2% Triton X-100 in PBS,
cells were preincubated at 37 °C in PBS containing 0.3% Triton
X-100, 1% bovine serum albumin, and 1% goat serum (blocking buffer).
After 45 min, the antibody against eNOS (final dilution 1/10) or NCX
(final dilution 1/500) was added, and cells were incubated for 90 min
at 37 °C. Cells were then washed three times with blocking buffer
and incubated with fluorescein isothiocyanate-conjugated anti-rabbit
IgG in blocking buffer (dilution 1/200) for 90 min at 37 °C. After 2 washes with 0.2% Triton X-100 in PBS and 1 wash with PBS, cells were
mounted in PBS containing 50% glycerol and 0.1%
p-phenylendiamine, pH 8.0. Fluorescence microscopy was
carried out on a Leica TCS 4D confocal microscope equipped with an
Ar/Kr laser and set up with the appropriate filter set for fluorescein
isothiocyanate detection (488 nm excitation, TK515 beam splitter,
BP-fluorescein isothiocyanate emission filter).
Fig. 1 shows a representative
experiment in which endothelial Ca2+ stores were depleted
with thapsigargin, followed by induction of capacitative
Ca2+ entry by CaCl2. The addition of 0.1 µM thapsigargin to endothelial cells suspended in
nominally Ca2+-free incubation buffer evoked a transient
rise in intracellular free Ca2+ levels
([Ca2+]i) due to the release of Ca2+
from intracellular stores. After [Ca2+]i had
declined back to basal values, capacitative Ca2+ entry was
induced by adding increasing concentrations of CaCl2, resulting in a stepwise increase in [Ca2+]i. To
determine the correlation between extracellular and intracellular free
Ca2+, the extracellular concentrations of Ca2+
([Ca2+]e) were measured with a
Ca2+-sensitive electrode in parallel experiments, and
[Ca2+]e was plotted against the respective
steady-state levels of [Ca2+]i (Fig.
2A). The data showed that
[Ca2+]i increased from a basal level of 162 ± 12 nM (mean ± S.E., n = 12) at 20 nM [Ca2+]e up to 663 ± 23 nM (mean ± S.E., n = 12) at 11.2 mM [Ca2+]e under control
conditions.
To test for a contribution of NCX in Ca2+ homeostasis,
endothelial cells were loaded with Na+ by incubation with
the Na+ ionophore monensin, which is known to promote
Ca2+ entry via reversed mode
Na+/Ca2+ exchange (26, 36). Alternatively,
Na+ was omitted from the extracellular solution and
replaced by choline chloride to avoid Na+ loading of the
cells. As shown in Fig. 2A, replacement of Na+
by choline chloride in the extracellular solution did not change the
correlation between the extracellular and the corresponding intracellular Ca2+ levels under control conditions.
Preincubation of endothelial cells with the Na+-ionophore
monensin (1 µM) in Na+-containing solution
markedly reduced [Ca2+]i from 663 ± 23 nM to 278 ± 27 nM (mean ± S.E.,
n = 8-12) at 11.2 mM
[Ca2+]e, indicating that Na+ loading
inhibits rather than augments Ca2+ entry. Thus, an
involvement of reversed mode Na+/Ca2+ exchange
in homeostasis of overall [Ca2+]i was not
detectable in these experiments. Since a monensin-induced reduction of
[Ca2+]i was not observed in Na+-free
buffer (Fig. 2A), the effect of monensin was presumably due
to Na+ entry and consequent membrane depolarization, which
is known to suppress store-operated Ca2+ entry.
The addition of CaCl2 to store-depleted endothelial cells
increased eNOS activity as expected from Ca2+ entry into
the cells (Fig. 2B, open circles). Interestingly, replacement of extracellular Na+ by choline chloride
(filled circles) induced a rightward shift of the
concentration response curve despite a lack of effect on Ca2+ entry (cf. Fig. 2A). In the
presence of monensin, the discrepancy between the effects of
extracellular Ca2+ on [Ca2+]i and
eNOS activity was even more pronounced. As shown in Fig. 2B
(open squares), Na+ loading with the
Na+ ionophore potentiated the effect of extracellular
Ca2+ on eNOS activity despite a marked reduction in overall
[Ca2+]i (cf. Fig. 2A).
Similar to the monensin-induced reduction of
[Ca2+]i, the effect of the Na+
ionophore on eNOS activity was completely abolished when extracellular Na+ was replaced by choline chloride (Fig. 2B,
filled squares). To evaluate the Ca2+ dependence
of eNOS activation under the various conditions, a correlation was
drawn between L-citrulline formation and
[Ca2+]i (Fig. 2C). The data revealed
that, under control conditions, half-maximal activation of eNOS
occurred at a [Ca2+]i of ~310 nM,
whereas the EC50 was ~390 nM in nominal Na+-free buffer. Pretreatment of the cells with monensin in
the presence of Na+ resulted in a pronounced leftward shift
of the concentration response curve (EC50 ~ 210 nM), but the Na+-ionophore had no effect in the
absence of extracellular Na+ (EC50 ~ 390 nM).
To test whether the monensin-induced facilitation of eNOS activation
was due to a change in cellular Na+ gradients or rather a
general phenomenon associated with membrane depolarization and/or
inhibition of Ca2+ entry, we investigated the effects of
K+-induced membrane depolarization and inhibition of
Ca2+ entry by SK&F 96365. As evident from Fig.
3A, treatment of the cells
with 30 µM SK&F 96365 markedly reduced Ca2+
entry ([Ca2+]i = 294 ± 14 nM
(mean ± S.E., n = 6) at 11.2 mM
[Ca2+]e). A similar, albeit less pronounced
effect was observed when experiments were performed in high
K+ buffer ([Ca2+]i = 531 ± 28 nM (mean ± S.E., n = 6) at 10.3 mM [Ca2+]e). In accordance with their
effects on [Ca2+]i, both SK&F 96365 and KCl
diminished the stimulation of eNOS by extracellular Ca2+
(Fig. 3B). Consequently, the correlation between
L-citrulline formation and [Ca2+]i
was neither affected by SK&F 96365 nor by KCl (Fig. 3C),
demonstrating that the potentiation of
Ca2+-dependent eNOS activation observed in
Na+-loaded endothelial cells was not related to diminished
Ca2+ entry and/or membrane depolarization.
Thus, Na+-loading-induced facilitation of endothelial NO
synthesis appears to be mediated either by a direct effect of
Na+ ions on the enzyme or by a local elevation of free
[Ca2+]i due to reversed mode
Na+/Ca2+ exchange, which is not detectable by
measurement of overall Ca2+ signals. Direct effects of
Na+ on the Ca2+ sensitivity of eNOS were
studied by measuring Ca2+-dependent activation
of the enzyme in homogenates of endothelial cells. The data revealed
that Na+ ions up to 100 mM failed to modify the
effects of Ca2+ on enzyme activity (EC50 for
Ca2+ = 0.19 ± 0.02 µM and 0.20 ± 0.03 µM (mean ± S.E., n = 4 each) in the absence and presence of 100 mM Na+,
respectively). We, therefore, tested whether DCB, an inhibitor of
Na+/Ca2+ exchange, influences the effects of
Na+ loading. For comparison, amiloride, a structural analog
of DCB that barely affects Na+/Ca2+ exchange
but inhibits Na+/H+ exchange and nonselective
cation channels (37), was studied. Since both compounds interfered with
the fluorometric detection of [Ca2+]i, the
respective experiments were confined to the measurements of
L-citrulline formation. As shown in Fig.
4, treatment of endothelial cells with 30 µM amiloride did not modify the effects of extracellular Ca2+ on eNOS activity in Na+-loaded cells
(EC50 ~ 0.3 mM). However, in the presence of
30 µM DCB, the Ca2+ sensitivity of
L-citrulline formation was markedly reduced, resulting in
an EC50 of ~1.5 mM, which is comparable to
the value observed in Na+-free buffer. These data strongly
support the concept that Na+-dependent
facilitation of eNOS activation is due to Ca2+ entry via
reversed mode Na+/Ca2+ exchange.
Na+/Ca2+ Exchange Facilitates
Ca2+-dependent Activation of Endothelial
Nitric-oxide Synthase*
,
Institut für Biochemie und Lebensmittelchemie,
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-[3-(4-methoxyphenyl)-propoxy]-4-methoxyphenethyl)-1H-imidazole hydrochloride (SK&F 96365) mimicked the effects of Na+
loading. The effects of monensin were completely blocked by
3',4'-dichlorobenzamil, a potent and selective inhibitor of NCX,
whereas the structural analog amiloride, which barely affects
Na+/Ca2+ exchange, was ineffective. Consistent
with a pivotal role of Na+/Ca2+ exchange in
Ca2+-dependent activation of eNOS, an NCX
protein was detected in caveolin-rich membrane fractions containing
both eNOS and caveolin-1. These results demonstrate for the first time
a crucial role of cellular Na+ gradients in regulation of
eNOS activity and suggest that a tight functional interaction between
endothelial NCX and eNOS may take place in caveolae.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-[3-(4-methoxyphenyl)-propoxy]-4-methoxyphenethyl)-1H-imidazole hydrochloride) was purchased from Biomol Research Laboratories, Plymouth Meeting, PA, and 3',4'-dichlorobenzamil hydrochloride (DCB)
was from Molecular Probes, Eugene, Oregon. Monoclonal anti-caveolin-1 antibody was from Transduction Laboratories purchased through Margaritella (Vienna, Austria), and polyclonal anti-NCX antibody was
from Swant (Bellinzona, Switzerland). Preliminary experiments were
performed with a monoclonal anti-NCX antibody kindly provided by H. Porzig (Bern, Switzerland). Polyclonal anti-eNOS antibody was raised in
rabbits against purified bovine eNOS (27). All other compounds
including secondary antibodies were purchased from Sigma.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (18K):
[in a new window]
Fig. 1.
Effect of store depletion and readdition of
extracellular Ca2+ on overall [Ca2+]i
in endothelial cells. Endothelial cells were loaded with FURA-2
and suspended in nominal Ca2+-free buffer containing 100 mM Na+. [Ca2+]i was
monitored by measuring the fluorescence intensity at 340/380 nm. Given
are the final concentrations of thapsigargin and CaCl2
added at the time points indicated by arrows. Shown is an
original trace representative for 12 experiments.

View larger version (22K):
[in a new window]
Fig. 2.
Effects of Na+ loading on overall
[Ca2+]i and eNOS activation. Endothelial
cells were preincubated with 0.1 mM thapsigargin in nominal
Ca2+-free buffer containing 100 mM
Na+ (open symbols) or choline chloride
(filled symbols) in the absence (circles) or
presence of 1 µM monensin (squares). After 15 min, CaCl2 was added (final concentrations ~0.01 to ~10
mM), and overall [Ca2+]i or eNOS
activity was monitored as described under "Experimental
Procedures." The extracellular concentrations of Ca2+
were measured with a Ca2+-sensitive electrode in parallel
experiments and plotted against the respective steady-state levels of
[Ca2+]i (panel A) or the formation of
L-citrulline (panel B). In panel C,
the correlation between L-citrulline formation and
[Ca2+]i is shown. Data are mean values ± S.E. of 6 to 12 experiments.

View larger version (21K):
[in a new window]
Fig. 3.
Effects of K+ and SK&F 96365 on
overall [Ca2+]i and eNOS activation.
Endothelial cells were preincubated with 0.1 mM
thapsigargin in nominal Ca2+-free buffer containing 100 mM Na+ (open circles), 100 mM Na+ plus 30 µM SK&F 96365 (filled circles) or 20 mM Na+ plus
100 mM K+ (open squares). After 15 min, CaCl2 was added (final concentrations ~0.01 to ~10
mM), and overall [Ca2+]i or eNOS
activity was monitored as described under "Experimental
Procedures." The extracellular concentrations of Ca2+
were measured with a Ca2+-sensitive electrode in parallel
experiments and plotted against the respective steady-state levels of
[Ca2+]i (panel A) or the formation of
L-citrulline (panel B). In panel C,
the correlation between L-citrulline formation and
[Ca2+]i is shown. Data are mean values ± S.E. of 6 to 12 experiments.

View larger version (21K):
[in a new window]
Fig. 4.
Effects of amiloride and DCB on eNOS
activation in Na+-loaded cells. Endothelial cells were
preincubated with 0.1 mM thapsigargin and 1 µM monensin in nominal Ca2+-free buffer
containing 100 mM Na+ (open
circles), 100 mM Na+ plus 30 µM amiloride (filled circles), 100 mM Na+ plus 30 µM DCB (open
squares), or 100 mM choline chloride (filled
squares). After 15 min, CaCl2 was added (final
concentrations ~0.01 to ~10 mM), and eNOS activity was
monitored as described under "Experimental Procedures." The
extracellular concentrations of Ca2+ were measured with a
Ca2+-sensitive electrode in parallel experiments and
plotted against the respective L-citrulline data. Data are
mean values ± S.E. of 6 experiments.
Similar to the results obtained with store-depleted endothelial cells,
Na+ loading also facilitated eNOS activation in resting and
bradykinin-stimulated cells. As shown in Fig.
5, basal L-citrulline
formation under control conditions (i.e. in the presence of
100 mM Na+ and 2.5 mM
Ca2+) was 2.4 ± 0.5% and stimulated up to 17.2 ± 2.1% upon addition of bradykinin (mean ± S.E.,
n = 4 each). Pretreatment of the cells with monensin (1 µM) not only potentiated the effect of bradykinin but
also enhanced eNOS activity ~3-fold in the absence of the agonist. No
effects of the Na+-ionophore were observed when experiments
were performed in Na+-free buffer.
|
Since the effect of Na+ loading was not associated with
elevated overall [Ca2+]i (cf. Fig.
2A), we speculated that the involved NCX is localized in
close proximity of eNOS and, thus, preferentially regulates the
Ca2+ concentration in the local environment of the enzyme.
This hypothesis would imply that the NCX protein is present in
caveolae. We, therefore, fractionated endothelial cell homogenates on a
discontinuous sucrose gradient and analyzed the fractions by
immunoblotting (Fig. 6, upper
panel). In accordance with other reports (33, 38), the caveolae
structural protein, caveolin-1, was found at the interface between the
5 and 35% sucrose layer (fraction 2). The caveolin-rich membrane
fraction also contained the majority of eNOS, but minor portions of the
enzyme were found in higher density fractions. In contrast to
caveolin-1 and eNOS, the NCX protein was found in all fractions of the
density gradient. To determine the proportion of NCX relative to the
total protein (Fig. 6, lower panel), we quantified the NCX
bands by densitometric analysis. The data revealed that NCX was
substantially enriched in fractions 1 (~25-fold) and 2 (~5-fold),
which represent plasma membrane vesicles of low density and caveolae,
respectively.
|
To get further insights into the subcellular distribution of eNOS and
NCX, the localization of both proteins was investigated by
immunofluorescence microscopy. Consistent with the immunoblotting data,
a substantial immunoreactivity against the NCX antibody was observed in
regions of the plasma membrane, the Golgi, and the cytoskeleton (Fig.
7, upper image), whereas in
most cells investigated, eNOS immunostaining was restricted to the
plasma membrane (Fig. 7, lower image), and only a minority
of cells showed an additional staining in the perinuclear region (data
not shown). These data suggest that both eNOS and NCX are indeed
present in caveolae and support our concept that
Na+/Ca2+ exchange may play a prominent role in
the regulation of eNOS activity.
|
| |
DISCUSSION |
|---|
|
|
|---|
As several previous reports have indicated the contribution of Na+/Ca2+ exchange to Ca2+ homeostasis in endothelial cells (11, 26, 36), it was of interest to study the role of NCX in cellular regulation of eNOS activity. Thereby, overall intracellular Ca2+ levels and L-citrulline formation were determined in parallel. The readdition of extracellular Ca2+ after store depletion with thapsigargin in nominally Ca2+-free incubation buffer allowed for reproducible and sustained elevation of [Ca2+]i and for reliable determination of Ca2+ concentration response curves. Two approaches were used to test for a contribution of NCX in the control of eNOS: (i) the cellular Na+ gradient was altered by use of monensin, and (ii) NCX was selectively blocked by DCB.
Na+ Loading Facilitates Ca2+-dependent Activation of eNOS-- Na+ loading of endothelial cells is an intervention that was used previously to demonstrate NCX-mediated Ca2+ signals in endothelial cells (26, 36). In those studies, transient rises in overall [Ca2+]i were observed when extracellular Na+ was removed after agonist stimulation of Na+-loaded endothelial cells. However, we observed that Na+ loading reduced overall [Ca2+]i of thapsigargin-stimulated cells. This result is probably explained by the fact that in the present study total steady-state levels of [Ca2+]i were analyzed instead of the increments of [Ca2+]i induced by Na+ removal. The total, steady-state level of [Ca2+]i after stimulation with thapsigargin is the result of Ca2+ entry via store-operated Ca2+ channels and concomitant Ca2+ transport via exchange mechanisms (NCX, Ca2+-ATPase). Na+ loading promotes Ca2+ entry via reversed mode Na+/Ca2+ exchange (26, 36) but suppresses store-operated Ca2+ entry via a reduction of the electrochemical gradient (25, 39). In our experimental setup, inhibition of store-operated Ca2+ entry was apparently the prominent effect of Na+ loading and masked the contribution of other Ca2+ transport systems, e.g. Na+/Ca2+ exchange. Treatment of endothelial cells with monensin augmented NOS activity without detectable changes of [Ca2+]i, resulting in a striking change in the correlation between overall [Ca2+]i and eNOS activity. This facilitation of eNOS stimulation was clearly dependent on the entry of Na+ ions, since preincubation of endothelial cells with monensin in the absence of Na+ failed to affect Ca2+-dependent enzyme activation. Thus, our results provide the first evidence for a role of Na+ ions in cellular regulation of eNOS.
Mechanism of Na+-dependent Facilitation of eNOS Activation-- Various mechanisms such as direct modulation of eNOS activity by Na+ ions, membrane depolarization, changes in intracellular pH, or Na+/Ca2+ exchange may explain the observed Na+-dependent facilitation of eNOS activation. A direct modulatory effect of Na+ ions on Ca2+ sensitivity of the enzyme was excluded in experiments with cell-free eNOS preparations. Moreover, the Na+ entry-induced membrane depolarization itself is apparently not involved in promotion of eNOS activation, since the effect of monensin was not mimicked by elevation of extracellular K+. Similarly, a mechanism based on changes in intracellular pH can be excluded, since Na+ loading did not significantly affect intracellular pH of endothelial cells.2 Moreover, amiloride, a potent inhibitor of Na+/H+ exchange, did not prevent the effects of monensin. In contrast to amiloride, the structural analog DCB, which is a potent inhibitor of Na+/Ca2+ exchange, completely prevented Na+-induced facilitation of eNOS activation. These results strongly support the view that the observed effects of Na+ loading were indeed due to reversed mode Na+/Ca2+ exchange. Since we did not detect an elevation of overall [Ca2+]i in Na+-loaded cells, the increase in [Ca2+]i induced by Na+/Ca2+ exchange may be restricted to the subplasmalemmal region. It appears reasonable to speculate about a buildup of a subcellular Ca2+ gradient, since such preferential elevation of subplasmalemmal [Ca2+]i has been also observed upon activation of endothelial cells with bradykinin or sodium fluoride (11).
Presence of Endothelial NCX in Caveolae-- The hypothesis that Na+ loading enhances eNOS activity via reversed mode Na+/Ca2+ exchange and focal rises in subplasmalemmal [Ca2+]i requires the assumption that the involved NCX protein is located in close proximity of eNOS. Since regulation of eNOS is likely to take place in caveolae, it appeared of interest to test for the presence of NCX in these specialized plasma membrane domains. Separation of endothelial cell homogenates on a discontinuous sucrose gradient revealed the presence of both eNOS and NCX in the caveolin-1-positive fraction. In accordance with a previous report, eNOS was also found in higher density fractions, presumably representing Golgi-associated and cytosolic enzyme (38). Interestingly, the proportion of caveolae-associated eNOS reported by these authors was ~35% and, thus, considerably lower than observed in the present study (~90%). This variation in the subcellular distribution may be explained by variability of eNOS localization due to species differences, type of endothelial cells, or culture conditions (1, 40).
The predominant localization of eNOS in caveolae observed in our study was confirmed by immunofluorescence microscopy. Consistent with previous immunofluorescence staining of eNOS in bovine aortic endothelial cells (40), we observed that the majority of cells exhibited a substantial immunoreactivity in the plasma membrane region, whereas a perinuclear staining was only found in a minority of cells. In contrast to this heterogeneous pattern of eNOS staining, the immunoreactivity against the NCX antibody did not exhibit considerable cell-to-cell variations; as in all cells investigated, a substantial staining in the regions of the plasma membrane, the Golgi, and the cytoskeleton was observed. Consistent with these immunofluorescence data, NCX was enriched in the plasma membrane and caveolae fractions of the sucrose gradient but was also present in higher density fractions. Albeit eNOS and NCX exhibit a clearly different pattern of subcellular localization, our results strongly suggest the presence of both proteins in caveolae. Since eNOS has been shown to interact with a variety of proteins present in caveolae (e.g. the structural protein caveolin-1 (5-7), the bradykinin receptor B2 (41), or the L-arginine transporter CAT-1 (42)), it is reasonable to speculate that eNOS may also form a complex with NCX. However, we did not observe a substantial coimmunoprecipitation of eNOS and NCX from endothelial cell lysates,3 indicating that both proteins apparently do not form a tight and stable complex.
Regulation of Endothelial Ca2+ Homeostasis by
Na+ Ions--
Based on our data, we suggest that
Ca2+ concentrations at the cytoplasmic side of caveolae
and, thus, eNOS activity is for a large part controlled by
Na+/Ca2+ exchange and propose the following
model (Fig. 8).
Ca2+-dependent stimulation of eNOS in
endothelial cells involves two distinct Ca2+ transport
systems in the plasma membrane. Ca2+ channels, activated by
depletion of intracellular Ca2+ stores, provide a general
pathway for Ca2+ entry into activated endothelial cells.
Albeit store-operated Ca2+ entry is the major determinant
of the overall Ca2+ signal observed in agonist-stimulated
endothelial cells, essential subcellular Ca2+ gradients are
established by Na+/Ca2+ exchange. An NCX
protein is present in caveolae and, thus, in close proximity of eNOS.
Thereby, NCX essentially contributes to local Ca2+
homeostasis and cellular control of eNOS activity. This interaction between eNOS and NCX allows for modulation of eNOS activity via the
cellular Na+ gradient and, thus, via a variety of
Na+ transport systems.
|
Physiological and Pathophysiological Implications-- In the present study, Ca2+-dependent activation of eNOS was primarily investigated in store-depleted endothelial cells. This method is widely accepted as a physiological relevant model of endothelial cell activation, since direct depletion of intracellular Ca2+ stores by inhibitors of endoplasmic Ca2+-ATPase such as thapsigargin mimics the stimulation of phospholipase C-coupled receptors in terms of Ca2+/NO signaling due to activation of the same Ca2+ entry pathway (8, 30). It is therefore conceivable to conclude that the effects of Na+ loading observed in thapsigargin-treated endothelial cells will take place similarly in cells activated by stimulation of phospholipase C-coupled receptors. Consistently, we observed that Na+ loading of endothelial cells also potentiates eNOS activation by bradykinin due to Ca2+ entry via reversed mode Na+/Ca2+ exchange.
In the absence of Na+ loading, forward mode
Na+/Ca2+ exchange is likely to contribute to
Ca2+ extrusion during cell activation (11). It appears
reasonable to expect that even a moderate elevation of intracellular
Na+, in particular in association with membrane
depolarization, may substantially suppress Ca2+ extrusion
and, thus, facilitates Ca2+-dependent
activation of eNOS. The contribution of
Na+/Ca2+ exchange is likely to vary, depending
on the ability of a physiological stimulus to induce Na+
loading (36). The recent demonstration of an inositol
1,4,5-trisphosphate-dependent, endothelial Na+
permeability suggests that various hormones or neurotransmitters are
able to affect endothelial Na+ gradients (43). In
pathophysiological situations such as oxidative stress, excessive
Na+ entry via redox-activated cation channels has been
observed (44, 45). The resulting profound Na+ loading is
expected to shift Na+/Ca2+ exchange to reversed
mode, thereby promoting the buildup of an even more pronounced
subplasmalemmal Ca2+ gradient. These Ca2+
gradients are likely to control not only eNOS but also other Ca2+-dependent proteins that are present in
caveolae (46). Therefore, we suggest Na+/Ca2+
exchange as a physiological and pathophysiological link between Na+ homeostasis and caveolae-associated cell signaling.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Margit Rehn and Renate Schmidt for excellent technical assistance and Dr. H. Porzig for providing an NCX antibody.
| |
FOOTNOTES |
|---|
* This work was supported by Austrian Science Fund Grants SFB Biomembranes F715 (to K. G.) and F706 (to S. D. K.), P12191 (to K. S.), and P13586 (to B. M.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ To whom correspondence should be addressed. Tel.: 43-316-380-5565; Fax: 43-316-380-9890; E-mail: kurt.schmidt@kfunigraz.ac.at.
2 K. Groschner, unpublished observations.
3 M. Teubl and K. Schmidt, unpublished observations.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
eNOS, endothelial nitric-oxide synthase (type 3);
DCB, 3',4'-dichlorobenzamil
hydrochloride;
[Ca2+]e, extracellular free
Ca2+ concentration;
[Ca2+]i, intracellular free Ca2+ concentration;
FURA-2-AM, FURA-2-acetoxymethylester;
MES, 4-morpholineethanesulfonic acid;
NCX, Na+/Ca2+ exchanger;
NO, nitric oxide;
NOS, nitric-oxide synthase;
PBS, phosphate-buffered saline;
SK&F 96365, 1-(
-[3-(4-methoxyphenyl)-propoxy]-4-methoxyphenethyl)-1H-imidazole
hydrochloride.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Garcia-Cardena, G.,
Oh, P.,
Liu, J. W.,
Schnitzer, J. E.,
and Sessa, W. C.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
6448-6453 |
| 2. |
Shaul, P. W.,
Smart, E. J.,
Robinson, L. J.,
German, Z.,
Yuhanna, I. S.,
Ying, Y.,
Anderson, R. G. W.,
and Michel, T.
(1996)
J. Biol. Chem.
271,
6518-6522 |
| 3. |
Lisanti, M. B.,
Scherer, P. E.,
Vidugiriene, J.,
Tang, Z.,
Hermanowski-Vosatka, A.,
Tu, Y.-H.,
Cook, R. F.,
and Sargiacomo, M.
(1994)
J. Cell Biol.
126,
111-126 |
| 4. | Anderson, R. G. W. (1998) Annu. Rev. Biochem. 67, 199-225[CrossRef][Medline] [Order article via Infotrieve] |
| 5. |
Michel, J. B.,
Feron, O.,
Sacks, D.,
and Michel, T.
(1997)
J. Biol. Chem.
272,
15583-15586 |
| 6. |
Ju, H.,
Zou, R.,
Venema, V. J.,
and Venema, R. C.
(1997)
J. Biol. Chem.
272,
18522-18525 |
| 7. |
Garcia-Cardena, G.,
Martasek, P.,
Masters, B. S. S.,
Skidd, P. M.,
Couet, J.,
Li, S. W.,
Lisanti, M. P.,
and Sessa, W. C.
(1997)
J. Biol. Chem.
272,
25437-25440 |
| 8. | Schilling, W. P., Cabello, O. A., and Rajan, L. (1992) Biochem. J. 284, 521-530 |
| 9. |
Dolor, R. J.,
Hurwitz, L. M.,
Mirza, Z.,
Strauss, H. C.,
and Whorton, A. R.
(1992)
Am. J. Physiol.
262,
C171-C181 |
| 10. | Gericke, M., Droogmans, G., and Nilius, B. (1993) Pflugers Arch. Eur. J. Physiol. 422, 552-557[CrossRef][Medline] [Order article via Infotrieve] |
| 11. |
Graier, W. F.,
Paltauf-Doburzynska, J.,
Hill, B. J. F.,
Fleischhacker, E.,
Hoebel, B. G.,
Kostner, G. M.,
and Sturek, M.
(1998)
J. Physiol. (Lond.)
506,
109-125 |
| 12. |
Paltauf-Doburzynska, J.,
Posch, K.,
Paltauf, G.,
and Graier, W. F.
(1998)
J. Physiol. (Lond.)
513,
369-379 |
| 13. |
Reuter, H.,
and Seitz, N.
(1968)
J. Physiol. (Lond.)
195,
451-470 |
| 14. |
Eisner, D. A.,
and Lederer, W. J.
(1985)
Am. J. Physiol.
248,
C189-C202 |
| 15. | Crespo, L. N., Grantham, C. J., and Cannell, M. B. (1990) Nature 345, 618-621[CrossRef][Medline] [Order article via Infotrieve] |
| 16. |
Bridge, J. H. B.,
Smolley, J. R.,
and Spitzer, K. W.
(1990)
Science
248,
376-378 |
| 17. | Cannell, M. B. (1991) Ann. N. Y. Acad. Sci. 639, 428-443[CrossRef][Medline] [Order article via Infotrieve] |
| 18. |
Leblanc, N.,
and Hume, J. R.
(1990)
Science
248,
372-378 |
| 19. |
Levi, A. J.,
Brooksby, P.,
and Hancox, J. C.
(1993)
Cardiovasc. Res.
27,
1677-1690 |
| 20. |
Juhaszova, M.,
Ambesi, A.,
Lindenmayer, G. E.,
Bloch, R. J.,
and Blaustein, M. P.
(1994)
Am. J. Physiol.
266,
C234-C242 |
| 21. |
Quednau, B. D.,
Nicoll, D. A.,
and Philipson, K. D.
(1997)
Am. J. Physiol.
272,
C1250-C1261 |
| 22. |
Winquist, R. J.,
Bunting, P. B.,
and Schofield, T. L.
(1985)
J. Pharmacol. Exp. Ther.
235,
644-650 |
| 23. | Schoeffter, P., and Miller, R. C. (1986) Mol. Pharmacol. 30, 53-57[Abstract] |
| 24. |
Cannell, M. B.,
and Sage, S. O.
(1989)
J. Physiol. (Lond.)
419,
555-568 |
| 25. |
Laskey, R. E.,
Adams, D. J.,
Johns, A.,
Rubanyi, G. M.,
and van Breemen, C.
(1990)
J. Biol. Chem.
265,
2613-2619 |
| 26. |
Sage, S. O.,
van Breemen, C.,
and Cannell, M. B.
(1991)
J. Physiol. (Lond.)
440,
569-580 |
| 27. | List, B. M., Klösch, B., Völker, C., Gorren, A. C. F., Sessa, W. C., Werner, E. R., Kukovetz, W. R., Schmidt, K., and Mayer, B. (1997) Biochem. J. 323, 159-165 |
| 28. | Schmidt, K., Mayer, B., and Kukovetz, W. R. (1989) Eur. J. Pharmacol. 170, 157-166[CrossRef][Medline] [Order article via Infotrieve] |
| 29. |
Groschner, K.,
Graier, W. F.,
and Kukovetz, W. R.
(1994)
Circ. Res.
75,
304-314 |
| 30. | Encabo, A., Romanin, C., Birke, F. W., Kukovetz, W. R., and Groschner, K. (1996) Br. J. Pharmacol. 119, 702-706[Medline] [Order article via Infotrieve] |
| 31. |
Pfeiffer, S.,
Schrammel, A.,
Koesling, D.,
Schmidt, K.,
and Mayer, B.
(1998)
Mol. Pharmacol.
53,
795-800 |
| 32. | Schmidt, K., Werner-Felmayer, G., Mayer, B., and Werner, E. R. (1999) Eur. J. Biochem. 259, 25-31[Medline] [Order article via Infotrieve] |
| 33. |
Song, K. S.,
Li, S.,
Okamoto, T.,
Quilliam, L. A.,
Sargiacomo, M.,
and Lisanti, M. P.
(1996)
J. Biol. Chem.
271,
9690-9697 |
| 34. |
Klatt, P.,
Heinzel, B.,
John, M.,
Kastner, M.,
Böhme, E.,
and Mayer, B.
(1992)
J. Biol. Chem.
267,
11374-11378 |
| 35. | Harlow, E., and Lane, D. (1988) Antibodies: A Laboratory Manual , pp. 386-387, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY |
| 36. |
Li, L.,
and van Breemen, C.
(1995)
Circ. Res.
76,
396-404 |
| 37. |
Siegl, P. K. S.,
Cragoe, E. J.,
Trumble, M. J.,
and Kaczorowski, G. J.
(1984)
Proc. Natl. Acad. Sci. U. S. A.
81,
3238-3242 |
| 38. | Venema, V. J., Zou, R., Ju, H., Marrero, M. B., and Venema, R. C. (1997) Biochem. Biophys. Res. Commun. 236, 155-161[CrossRef][Medline] [Order article via Infotrieve] |
| 39. | Groschner, K., Graier, W. F., and Kukovetz, W. R. (1992) Biochim. Biophys. Acta 1137, 162-170[Medline] [Order article via Infotrieve] |
| 40. |
Prabhakar, P.,
Thatte, H. S.,
Goetz, R. M.,
Cho, M. R.,
Golan, D. E.,
and Michel, T.
(1998)
J. Biol. Chem.
273,
27383-27388 |
| 41. |
Ju, H.,
Venema, V. J.,
Marrero, M. B.,
and Venema, R. C.
(1998)
J. Biol. Chem.
273,
24025-24029 |
| 42. |
McDonald, K. K.,
Zharikov, S.,
Block, E. R.,
and Kilberg, M. S.
(1997)
J. Biol. Chem.
272,
31213-31216 |
| 43. | Groschner, K., Hingel, S., Lintschinger, B., Balzer, M., Romanin, C., Zhu, X., and Schreibmayer, W. (1998) FEBS Lett. 437, 101-106[CrossRef][Medline] [Order article via Infotrieve] |
| 44. | Elliott, S. J., and Koliwad, S. K. (1995) Free Radic. Biol. Med. 19, 649-658[CrossRef][Medline] [Order article via Infotrieve] |
| 45. |
Balzer, M.,
Lintschinger, B.,
and Groschner, K.
(1999)
Cardiovasc. Res.
42,
543-549 |
| 46. |
Fujimoto, T.,
Hagiwara, H.,
Aoki, T.,
Kogo, H.,
and Nomura, R.
(1998)
J. Electron Microsc.
47,
451-460 |
| 47. | Philipson, K. D., Longoni, S., and Ward, R. (1988) Biochim. Biophys. Acta 945, 298-306[Medline] [Order article via Infotrieve] |
| 48. | Iwata, T., Galli, C., Dainese, P., Guerini, D., and Carafoli, E. (1995) Cell Calcium 17, 263-269[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
P. J. Mohler and X. H. T. Wehrens Mechanisms of Human Arrhythmia Syndromes: Abnormal Cardiac Macromolecular Interactions Physiology, October 1, 2007; 22(5): 342 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zhang, H. Dong, L. J. Rubin, and J. X.-J. Yuan Upregulation of Na+/Ca2+ exchanger contributes to the enhanced Ca2+ entry in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension Am J Physiol Cell Physiol, June 1, 2007; 292(6): C2297 - C2305. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Balijepalli, J. D. Foell, D. D. Hall, J. W. Hell, and T. J. Kamp From the Cover: Localization of cardiac L-type Ca2+ channels to a caveolar macromolecular signaling complex is required for beta2-adrenergic regulation PNAS, May 9, 2006; 103(19): 7500 - 7505. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Y. Kim, G. H. Seol, G. H. Liang, J. A. Kim, and S. H. Suh Na+-K+ pump activation inhibits endothel |